ACA
ABBV icon

Affinity Capital Advisors’s AbbVie ABBV Stock Holding History

Affinity Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$958K Sell
3,760
-58
-2% -$12.5K 0.12% 76
2026
Q1 		$830K Sell
3,818
-187
-5% -$41.5K 0.12% 76
2025
Q4 		$915K Buy
4,005
+564
+16% +$128K 0.13% 74
2025
Q3 		$814K Buy
3,441
+8
+0.2% +$1.63K 0.13% 76
2025
Q2 		$637K Buy
3,433
+10
+0.3% +$1.86K 0.11% 84
2025
Q1 		$599K Buy
3,423
+4
+0.1% +$778 0.12% 81
2024
Q4 		$614K Buy
3,419
+9
+0.3% +$1.66K 0.12% 81
2024
Q3 		$673K Buy
3,410
+8
+0.2% +$1.49K 0.13% 84
2024
Q2 		$584K Sell
3,402
-25
-0.7% -$4.14K 0.12% 86
2024
Q1 		$624K Buy
3,427
+37
+1% +$6.38K 0.14% 78
2023
Q4 		$525K Sell
3,390
-55
-2% -$8.02K 0.13% 82
2023
Q3 		$514K Buy
3,445
+173
+5% +$25.4K 0.14% 83
2023
Q2 		$441K Buy
3,272
+53
+2% +$7.77K 0.12% 80
2023
Q1 		$513K Sell
3,219
-30
-0.9% -$4.59K 0.16% 75
2022
Q4 		$525K Buy
3,249
+6
+0.2% +$920 0.18% 62
2022
Q3 		$435K Buy
3,243
+5
+0.2% +$717 0.15% 66
2022
Q2 		$496K Sell
3,238
-43
-1% -$6.57K 0.17% 65
2022
Q1 		$532K Buy
3,281
+54
+2% +$7.84K 0.17% 65
2021
Q4 		$437K Buy
3,227
+1
+0% +$118 0.13% 74
2021
Q3 		$348K Buy
3,226
+1
+0% +$114 0.12% 84
2021
Q2 		$363K Buy
3,225
+236
+8% +$26.6K 0.12% 85
2021
Q1 		$323K Buy
+2,989
New +$320K 0.12% 86

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Affinity Capital Advisors's ABBV Position: Q2 2026 in Review

Affinity Capital Advisors reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $12.5K and leaving 3,760 shares worth $958K. The position accounts for 0.12% of the portfolio, ranked #76.

Affinity Capital Advisors first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Affinity Capital Advisors held 3,760 shares of AbbVie worth $958K as of Q2 2026.
  • Affinity Capital Advisors sold 58 AbbVie shares in Q2 2026, an estimated $12.5K.
  • AbbVie made up 0.12% of Affinity Capital Advisors's portfolio in Q2 2026, its #76 holding.
  • Affinity Capital Advisors first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.